Pableo, Sheryl Amor .

HRN: 22-49-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
AMPICILLIN 1GM (VIAL)
01/17/2023
01/23/2023
IVTT
2gm
Q6
PROM 12HRS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: